{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(7)"],"submitter":["Maltoni R"],"journal":["Annals of translational medicine"],"pagination":["389"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9073799"],"repository":["biostudies-literature"],"pubmed_title":["Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer."],"pmcid":["PMC9073799"],"pubmed_authors":["Bravaccini S","Maltoni R"],"additional_accession":[]},"is_claimable":false,"name":"Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer.","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-27T03:16:11.215Z","creation":"2025-04-06T18:45:46.871Z"},"accession":"S-EPMC9073799","cross_references":{"pubmed":["35530936"],"doi":["10.21037/atm-21-6999"]}}